期刊文献+

依达拉奉对急性脑梗死患者血清血管内皮生长因子和肿瘤坏死因子水平的影响 被引量:29

Effect of Edaravone on the levels of serum vascular endothelial growth factor and tumor necrosis factor-α in patients with acute cerebral infarction
下载PDF
导出
摘要 目的探讨依达拉奉对急性脑梗死患者血清血管内皮生长因子(VEGF)和肿瘤坏死因子(TNF)-α水平的影响。方法 84例急性脑梗死患者随机分为依达拉奉组和对照组;在脑梗死常规治疗的基础上,依达拉奉组加用依达拉奉60 mg/d静脉滴注14 d。治疗前、治疗后14 d及28 d应用改良爱丁堡斯堪的那维亚量表(SSS)对患者进行临床神经功能缺损程度评分;应用酶联免疫吸附测定法检测患者发病3 d、7 d及14 d血清VEGF及TNF-α水平。结果两组患者治疗14 d及28 d时SSS评分均较治疗前明显降低(P<0.05~0.01),依达拉奉组各时间点SSS评分明显低于对照组(均P<0.05)。两组血清VEGF及TNF-α水平发病后各时间点较正常值明显增高,发病第7 d时明显高于第3 d和第14 d(均P<0.05);依达拉奉组各时间点血清VEGF水平明显低于对照组(均P<0.01);两组各时间点血清TNF-α水平差异无统计学意义。结论依达拉奉可明显降低急性脑梗死患者血清VEGF水平,减轻脑梗死后自由基导致的脑损害。 Objective To investigate Edaravone on the levels of serum vascular endothelial growth factor(VEGF) and tumor necrosis factor(TNF)-α in patients with acute cerebral infarction(ACI).Methods Eighty-four ACI patients were randomly divided into the Edaravone group and control group.On the basic of ACI routine treatment,Edaravone group received Edaravone 60 mg/d intravenous drip for 14 d.Pre and 14 d,28 d post treatment,the neurological deficits of all the patients were evaluated by Scandinavian Stroke Scale(SSS);the levels of serum VEGF and TNF-α were detected at 3 d,7 d and 14 d after onset,respectively by enzyme-linked immunosorbent assay.ResultsCompared with pre treatment,SSS of post treatment in the two groups were significantly decreased(P0.05-0.01),meanwhile,which in Edaravone group at each time point were significantly decrased than control group(all P0.05).The levels of serum VEGF and TNF-α at each time point in the two groups were significantly higher than normal values,and which at 7 d after onset were significantly higher than 3 d and 14 d after onset(all P0.05).The levels of serum VEGF at each time points in Edaravone group were significantly lower than the control group(all P0.01).The levels of serum TNF-α at each time point between the two groups were no statistical significance.Conclusion Edaravone can obviously decrease the levels of serum VEGF in ACI patients and reduce the brain damage caused free radical after ACI.
出处 《临床神经病学杂志》 CAS 北大核心 2012年第6期425-427,共3页 Journal of Clinical Neurology
关键词 依达拉奉 急性脑梗死 血管内皮生长因子 肿瘤坏死因子 Edaravone acute cerebral infarction vascular endothelial growth factor tumor necrosis factor
  • 相关文献

参考文献15

  • 1M(a)rg(a)ritescu O,Pirici D,M(a)rg(a)ritescu C. VEGF expression in human brain tissue after acute ischemic stroke[J].Romanian Journal of Morphology and Embryology,2011.1283.
  • 2Yan J,Greer JM,McCombe PA. Prolonged elevation of cytokine levels after human acute ischaemic stroke with evidence of individual variability[J].Journal of Neuroimmunology,2012.78.
  • 3Tuttolomondo A,di Raimondo D,di Sciacca R. Inflammatory cytokines in acute ischemic stroke[J].Current Pharmaceutical Design,2008.3574.
  • 4孔岳南,李学忠.依达拉奉对急性脑梗死患者血清基质金属蛋白酶-9水平和梗死后出血的影响[J].临床神经病学杂志,2009,22(2):136-138. 被引量:5
  • 5Watanabe T,Tanaka M,Watanabe K. Research and development of the free radical scavenger edaravone as a neuroprotectant[J].Yakugaku Zasshi:Journal of the Pharmaceutical Society of Japan,2004.99.
  • 6Tanaka M. Pharmacological and clinical profile of the free radical scavenger edaravone as a neuroprotective agent[J].Nihon Yakurigaku Zasshi,2002.301.
  • 7Nakase T,Yoshioka S,Suzuki A. Free radical scavenger,edaravone,reduces the lesion size of lacunar infarction in human brain ischemic stroke[J].Bmc Neuroscience,2011.39.
  • 8Ohta Y,Takamatsu K,Fukushima T. Efficacy of the free radical scavenger,edaravone,for motor palsy of acute lacunar infarction[J].Internal Medicine,2009.593.
  • 9Sharma P,Sinha M,Shukla R. A randomized controlled clinical trial to compare the safety and efficacy of edaravone in acute ischemic stroke[J].Ann Indian Acad Neurol,2011.103.
  • 10Kajdaniuk D,Marek B,Foltyn W. Vascular endothelial growth factor (VEGF)-part 1:in physiology and pathophysiology[J].Endokrynologia Polska,2011.444.

二级参考文献11

  • 1秦延昆,谢海洋.依达拉奉联合降纤酶治疗急性脑梗死的疗效观察[J].临床神经病学杂志,2005,18(3):218-219. 被引量:69
  • 2赵连东,晋光荣,徐汉荣,张海军,李云涛.依达拉奉对脑缺血再灌注大鼠脑组织及血清超氧化物歧化酶、一氧化氮、丙二醛水平的影响[J].临床神经病学杂志,2006,19(1):60-62. 被引量:66
  • 3Anna R, Arantxa OA, Jose AS, et al. Increased brain expression of matrix metalloproteinase-9 after ischemic and hemorrhagic human stroke[ J]. Stroke, 2006, 37 : 1399.
  • 4Kelly PJ, Morrow JD, Ning MM, et al. Oxidative stress and matrix metalloproteinase-9 in acute ischemic stroke[ J]. Stroke, 2008, 39 : 100.
  • 5Anna R, Eloy C, Arantxa OA, et al. MMP-9-positive neutrophil infiltration is associated to blood-brain barrier breakdown and basal lamina type IV collagen degradation during hemorrhagic transformation after human ischemic stroke[J]. Stroke, 2008, 39: 1121.
  • 6Liu K J, Rosenberg G. Matrix metalloproteinases and free radicals in cerebral ischemia[J]. Free Rad Biol Med, 2005, 39: 71.
  • 7Montaner J, Molina CA, Monasterio J, et al. Matrix metalloproteinase pre-treatment level predicts intracranial hemorrhage complications after thrombolysis in human stroke [ J ]. Circulation, 2003, 107 : 598.
  • 8Zhao BQ, Emiri T, Eng H, et al. Neurovascular proteases in brain injury, hemorrhage and remodeling after stroke [ J ]. Stroke, 2007,38 : 748.
  • 9Koizumi T, Tanaka H, Sakaki S, et al. The therapeutic efficacy of Edaravone in extensively burned rats[ J]. Arch Surg, 2006, 141: 992.
  • 10Maeno T, Tano R, Fukumoto M, et al. Efficacy of using a free radical scavenger, edaravone, systemically at arteriovenous sheathotomy for the treatment of macular edema associated with brvo [ J ]. Invest Ophthalmol Vis Sci, 2006, 47: 4483.

共引文献4

同被引文献289

引证文献29

二级引证文献407

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部